Key result
Pre-pregnancy Myadm knockdown mitigates offspring cardiac remodeling and cerebral inflammation in maternal pulmonary hypertension.
Why the study?
Pregnancy with pulmonary hypertension threatens mothers and infants, but the long-term effect of maternal PH on the postpartum growth of offspring and the role of pre-pregnancy Myadm intervention were unknown.
Does targeting Myadm reduce the adverse effects of maternal pulmonary hypertension on offspring's cardiac and cerebral systems in a rat model?
Does targeting Myadm reduce the adverse effects of maternal pulmonary hypertension on offspring's cardiac and cerebral systems in a rat model?
Targeting Myadm in maternal pulmonary hypertension may offer a therapeutic strategy to prevent or mitigate adverse cardiac and cerebral development in offspring.
Answers are grounded in this paper and cite their sources.
Should not alter maternal PH management; leaves open Myadm targeting for offspring protection in future studies.
Pregnancy with pulmonary hypertension (PH) seriously threatens the life and safety of mothers and infants. Here, the long-term effect of maternal PH on the postpartum growth of rat offspring was focused for the first time, as well as explored the role of Myadm in PH rats before pregnancy based upon the previous findings. Patients with PH are prone to hypoxemia, leading to insufficient placental structure and function, which affects the organ function of fetuses, followed by evidence that differently expressed genes (DEGs) existed in the heart of maternal PH newborn rats and enriched in pathways related to cardiac and nerve development on human infants with similar birth outcome: low birth weight (LBW). LBW was one of the possible birth outcomes of pregnancy with PH, especially severe PH, accompanied by evidence that offspring derived from mothers with PH presented lower birth weights and slower growth rates than those derived from normal control mothers in a rat model. Besides, maternal PH rat offspring showed cardiac remodeling and a significant elevation of the expression levels of hypoxia- and inflammation-related markers in the cerebral cortex at both 10 and 14 weeks of age, respectively. What is more, the previous studies found that the overexpression of Myadm could result in the remodeling of the pulmonary artery. And targeting Myadm to intervene PH before pregnancy could alleviate sustained low weight growth in maternal PH rat offspring, and the pathological changes of the cardiac-cerebral system caused by maternal PH, including enlarged right heart cavity, loss of cardiomyocytes, abnormal heart index, as well as cerebral cortex hypoxia and the inflammatory state as they grew up to a certain extent. The findings show the pathological significance of maternal PH on offspring growth and the cardiac-cerebral development in a rat model, as well as point out the potential treatment target, which may provide a further reference for pregnancy outcomes in women with PH and healthy development of offspring to some extent.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) studied Pregnancy with pulmonary hypertension. shRNA-Myadm vs. Monocrotaline-induced pulmonary hypertension without Myadm knockdown, and normal saline control was evaluated on Offspring growth rates and cardiac-cerebral pathological changes (remodeling, hypoxia, inflammation). Targeting Myadm to intervene in pulmonary hypertension before pregnancy alleviated sustained low weight growth, right heart cavity enlargement, and cerebral cortex hypoxia and inflammation in maternal PH rat offspring.
Synapse has enriched 10 related papers. Consider them for comparative context: